Clinical Trial Update: Study to Evaluate the Immunogenicity and Safety of a Heterologous Vaccine Regimen Against Ebola [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating immunogenicity and safety of a heterologous vaccine regimen for Ebola Virus Disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease

Snippet

Sponsor: Universiteit Antwerpen | Conditions: Ebola Virus Disease | Phase 2 | Status: COMPLETED